Latest Hatteras Venture Partners Stories
Pathfinder Therapeutics, Inc. (PTI), a medical device company focused on the development of "surgical GPS" systems for the abdomen, announced that it has closed on a $5.2 million Series A financing round led by Hatteras Venture Partners of Research Triangle Park, NC. Other investors included Florida Gulfshore Capital, Clayton & Associates, Nashville Capital Network, Lumira, and Vanderbilt University. Concurrent with the financing, Clay Thorp and Bob Morff, PhD, from Hatteras Venture...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.